Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

PROCEDURE(3)
DRUG(3)
RADIATION(1)
Intraarterial Cetxuimab (Erbitux)
1 trial
phase_1
northwell-health
Intra-arterial Mannitol
1 trial
phase_2
northwell-health
Laparoscopically harvested omental free flap
1 trial
phase_1
northwell-health
Hypofractionated re-irradiation
1 trial
phase_2
northwell-health
Tissue autograft of pedicled temporoparietal fascial (TPF) or pericranial flap to bypass the blood brain barrier (BBB)
1 trial
not_applicable
northwell-health
Laparoscopically harvested omental tissue autograft
1 trial
not_applicable
northwell-health
Intra-arterial Cetuximab
1 trial
phase_2
northwell-health
7 unique interventions3 categories

Analytics

Trial Phases

Phase 12
Phase 21

Trial Status

Completed1
Recruiting2
Terminated1
Other1

Role Distribution

Principal Investigator5
PI Rate100%

Activity Timeline

Clinical Trials (5)

NCT05979064Not ApplicableRecruiting
Omental Tissue Autograft in Human Recurrent Glioblastoma Multiforme (rGBM)
Brain CancerGBMGlioblastoma+5 more
PrincipalinvestigatorStart date: 2023-04-04
NCT04222309Phase 1Suspended
Laparoscopically Harvested Omental Free Tissue Autograft to Bypass the Blood Brain Barrier (BBB) in Human Recurrent Glioblastoma Multiforme (rGBM)
Brain CancerGBMGlioblastoma+4 more
PrincipalinvestigatorStart date: 2020-01-06
NCT03630289Not ApplicableCompleted
Surgical Tissue Flap to Bypass the Blood Brain Barrier in GBM
Brain CancerGBMGlioblastoma+1 more
PrincipalinvestigatorStart date: 2018-07-27
NCT02800486Phase 2Recruiting
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
Anaplastic AstrocytomaAnaplastic OligoastrocytomaBrain Cancer+6 more
PrincipalinvestigatorStart date: 2016-05-01
NCT02438995Phase 1Terminated
Super-Selective Intraarterial Infusion of Cetuximab (Erbitux) With or Without Radiation Therapy for the Treatment of Unresectable Recurrent Squamous Cell Carcinoma of the Head and Neck
Carcinoma, Squamous CellCarcinoma, Squamous Cell of Head and Neck
PrincipalinvestigatorStart date: 2015-05-01

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Kevin A camphausen, M.D.

National Cancer Institute (NCI)

Related
17 trials

Shared therapeutic areas:

GlioblastomaBrain NeoplasmsGlioblastoma Multiforme+1 more
Similarity Score9%

Maryam Fouladi, MD

Nationwide Children's Hospital

Related
10 trials

Shared therapeutic areas:

High Grade GliomaAnaplastic AstrocytomaGlioblastoma+1 more
Similarity Score9%

Michael B Gill

Power Life Sciences Inc.

Related
105 trials

Shared therapeutic areas:

GlioblastomaGlioblastoma MultiformeGlioma+1 more
Similarity Score9%

Gustavo Leone

Medical University of South Carolina, Hollings Cancer Center

Related
12 trials

Shared therapeutic areas:

Brain NeoplasmsGlioblastoma MultiformeGlioma
Similarity Score6%

Jeffrey Raizer, MD

Northwestern University

Related
8 trials

Shared therapeutic areas:

Malignant GliomaGBMGlioblastoma Multiforme
Similarity Score6%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

Brain CancerGlioblastomaMalignant Glioma
Similarity Score6%

Stanislaw R. Burzynski, MD, PhD

Burzynski Research Institute

Related
62 trials

Shared therapeutic areas:

Anaplastic AstrocytomaGlioblastoma Multiforme of BrainHigh Grade Glioma
Similarity Score6%

Lung-Ji Chang, PhD

Shenzhen Geno-Immune Medical Institute

Related
18 trials

Shared therapeutic areas:

Brain CancerGlioblastoma Multiforme of Brain
Similarity Score4%

Jean-Olivier ARNAUD, Director

Assistance Publique Hôpitaux de Marseille

Related
17 trials

Shared therapeutic areas:

Brain NeoplasmsGlioma
Similarity Score4%

Nancy Lee, MD

Memorial Sloan Kettering Cancer Center

Related
18 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of Head and NeckCarcinoma, Squamous Cell
Similarity Score4%

Publications (0)

No publications found for this investigator.

Clinical Trials (5)

Showing 5 of 5 trials

NCT05979064Not ApplicablePrincipalInvestigator

Omental Tissue Autograft in Human Recurrent Glioblastoma Multiforme (rGBM)

Brain CancerGBMGlioblastoma+5 more
Recruiting
NCT04222309Phase 1PrincipalInvestigator

Laparoscopically Harvested Omental Free Tissue Autograft to Bypass the Blood Brain Barrier (BBB) in Human Recurrent Glioblastoma Multiforme (rGBM)

Brain CancerGBMGlioblastoma+4 more
Suspended
NCT03630289Not ApplicablePrincipalInvestigator

Surgical Tissue Flap to Bypass the Blood Brain Barrier in GBM

Brain CancerGBMGlioblastoma+1 more
Completed
NCT02800486Phase 2PrincipalInvestigator

Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA

Anaplastic AstrocytomaAnaplastic OligoastrocytomaBrain Cancer+6 more
Recruiting
NCT02438995Phase 1PrincipalInvestigator

Super-Selective Intraarterial Infusion of Cetuximab (Erbitux) With or Without Radiation Therapy for the Treatment of Unresectable Recurrent Squamous Cell Carcinoma of the Head and Neck

Carcinoma, Squamous CellCarcinoma, Squamous Cell of Head and Neck
Terminated

All 5 trials loaded